FDA’s latest whitepaper shows how scalable quality management investments in pharma reduce costs, improve reliability, and ...

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with ...

Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has announced it successfully passed ...

With hundreds of drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions and mitigate financial losses. These include ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance to PathAI for its digital pathology image management system, AISight Dx, to be used in primary diagnosis in clinical settings.

More than 67,000 cases of Power Stick deodorants were recalled for deviating from Food and Drug Administration standards.

WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line: Wuxi, China Wednesday, July 23, 2025, 13:00 Hrs [IST] WuXi Biolog ...

Company's technology redefines dental prosthetics with revolutionary single-piece, multi-material dentures delivering ...

Overview of Nanotechnology Drug Delivery MarketThe global Nanotechnology Drug Delivery Market is valued at USD 97.98 Billion ...

During the latest Five-Year Plan, health authorities have sought to balance drug affordability and quality, as well as ...

In this exclusive Drug Digest video, Deepak Bahl from Roquette and Jagruti Patel from Lonza look at strategies for ...